ImmuniQ vs NewStem
ImmuniQ vs NewStem, compared side by side on 10 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: ImmuniQ is on 54/100 and NewStem on 45/100.
Where each one leads
ImmuniQ
- our overall score: 54/100 against 45/100
NewStem
- agent readiness: 50/100 against 22/100
At a glance
| Measure | ImmuniQ | NewStem |
|---|---|---|
| What it is | Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology. | Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy. |
| Category | Life Sciences, Oncology, Patient Care, Biotech | Life Sciences, Biotech, Biopharmaceutical, MedTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2021 | 2018 |
| Headquarters | Tel Aviv, Israel | Rehovot, Israel |
| Status | Inactive | Active |
Size, funding and growth
| Measure | ImmuniQ | NewStem |
|---|---|---|
| Total funding | Not published | $30.0M |
| Latest round | Not published | Series B |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | ImmuniQ | NewStem |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 54/100 | 45/100 |
| Traction | 11/100 | 37/100 |
| Team | Not published | 30/100 |
| Search visibility | Not published | 9/100 |
| Quality | Not published | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (22/100) | D (50/100) |
| Domain ratingLink authority, 0-100 | Not published | 4/100 |
ImmuniQ vs NewStem: common questions
Which is better, ImmuniQ or NewStem?
On our 0-100 score ImmuniQ rates higher (54/100 against 45/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 10 data points above: read the rows that match what you are buying for.
How do ImmuniQ and NewStem compare on the numbers?
ImmuniQ leads on our overall score (54/100 against 45/100). NewStem leads on agent readiness (50/100 against 22/100).
Read the full ImmuniQ review and pricing or the NewStem review and pricing. You can also browse other ImmuniQ alternatives we track.